Edgestream Partners, L.P. Amgen Inc Transaction History

Edgestream Partners, L.P.

$2.05 Billion
Q2 2024

A detailed history of Edgestream Partners, L.P. transactions in Amgen Inc stock. As of the latest transaction made, Edgestream Partners, L.P. holds 2,733 shares of AMGN stock, worth $863,628. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,733

Previous 12,434 78.02%

Holding current value

$863,628

Previous $3.54 Million 75.87%

% of portfolio

0.04%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $2.55 Million - $3.1 Million	-9,701 Reduced 78.02%	2,733 $853,000
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $2.29 Million - $2.77 Million	8,524 Added 218.01%	12,434 $3.54 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $601,917 - $679,034	-2,354 Reduced 37.58%	3,910 $1.13 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $190,881 - $236,984	873 Added 16.19%	6,264 $1.68 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $825,368 - $975,981	3,852 Added 250.29%	5,391 $1.2 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $575,538 - $701,484	-2,549 Reduced 62.35%	1,539 $372,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $676,096 - $859,061	-2,952 Reduced 41.93%	4,088 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.14 Million - $1.29 Million	5,088 Added 260.66%	7,040 $1.59 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $450,345 - $501,156	1,952 New	1,952 $475,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $8.04 Million - $9.2 Million	-40,427 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $8.58 Million - $10.1 Million	40,427 New	40,427 $8.6 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $6.22 Million - $7.25 Million	-28,039 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $12.4 Million - $14.7 Million	-57,214 Reduced 67.11%	28,039 $6.45 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $14.9 Million - $16.6 Million	63,433 Added 290.71%	85,253 $21.7 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $2.75 Million - $3.38 Million	13,908 Added 175.78%	21,820 $5.15 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $805,865 - $1.07 Million	4,422 Added 126.7%	7,912 $1.6 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $421,938 - $542,336	2,230 Added 176.98%	3,490 $841,000
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $12.4 Million - $14.8 Million	-70,977 Reduced 98.26%	1,260 $244,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $229,379 - $268,884	-1,376 Reduced 1.87%	72,237 $13.3 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $13.3 Million - $15 Million	73,613 New	73,613 $14 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $186,071 - $217,204	-1,043 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $193,257 - $217,872	1,043 New	1,043 $216,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Amgen Inc Transaction History